Testosterone and modifiable risk factors associated with diabetes in men

Maturitas

Volumn 68, Issue 3, 2011, Pages 279-285

  Atlantis, Evan ^a,b   Lange, Kylie ^c   Martin, Sean ^b   Haren, Matthew T ^d   Taylor, Anne ^d   O'Loughlin, Peter D ^a,b   Marshall, Villis ^b   Wittert, Gary A ^a,b,c  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Androgen; Diabetes; Glycosylated haemoglobin; Hyperglycaemia; SHBG; Testosterone

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; TESTOSTERONE; TRIACYLGLYCEROL;

ABDOMINAL FAT; ADULT; AGED; ALCOHOL CONSUMPTION; ARTHRITIS; ARTICLE; AUSTRALIA; BODY COMPOSITION; BONE MINERAL; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; DEPRESSION; DIASTOLIC BLOOD PRESSURE; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; GLYCEMIC LOAD; HUMAN; LEAN BODY WEIGHT; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICTURITION; MUSCLE STRENGTH; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; RISK FACTOR; SEDENTARY LIFESTYLE; SELF REPORT; SMOKING; SUGAR INTAKE; SYSTOLIC BLOOD PRESSURE; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; URINARY TRACT DISEASE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ARTHRITIS; AUSTRALIA; BLOOD GLUCOSE; BODY COMPOSITION; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIETARY SUCROSE; HUMANS; HYPERCHOLESTEROLEMIA; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK FACTORS; SELF REPORT; SMOKING; TESTOSTERONE; UROLOGIC DISEASES;

EID: 79951949413     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2010.12.007     Document Type: Article

References (52)

1. Barr ELM, Zimmet PZ, Welborn TA, et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 2007;116(2):151-7. (Pubitemid 47057520)
2. WeiM, Gaskill SP, Haffner SM, Stern MP. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 1998;21(July (7)):1167-72. (Pubitemid 28368527)
3. Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of B-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2006;29(May (5)):1130-9. (Pubitemid 44115261)
4. Barzilay JI, Spiekerman CF, Wahl PW, et al. Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria. The Lancet 1999;354(9179):622-5. (Pubitemid 29391425)
5. Barr E, Boyko E, Zimmet P,Wolfe R, Tonkin A, Shaw J. Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) Study. Diabetologia 2009;52(3):415-24.
6. Magliano DJ, Barr ELM, Zimmet PZ, et al. Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2008;31(February (2)):267-72. (Pubitemid 351213333)
7. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and prediabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009;32(February (2)):287-94.
8. Dunstan DW, Zimmet PZ, Welborn TA, et al. The rising prevalence of diabetes and impaired glucose tolerance. Diabetes Care 2002;25(May (5)):829-34.
9. Atlantis E, Lange K, Wittert GA. Chronic disease trends due to excess body weight in Australia. Obesity Reviews 2009;9999(9999).
10. Mozaffarian D, Kamineni A, Carnethon M, Djousse L, Mukamal KJ, Siscovick D. Lifestyle risk factors and new-onset diabetes mellitus in older adults: the Cardiovascular Health Study. Archives of Internal Medicine 2009;169(April (8)):798-807.
11. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006;295(March (11)):1288-99.
12. Shahani S, Braga-Basaria M, Basaria S. Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis. Journal of Clinical Endocrinology and Metabolism 2008;93(June (6)):2042-9. (Pubitemid 351831513)
13. Lage MJ, Barber BL, Markus RA. Association between androgen-deprivation therapy and incidence of diabetes among males with prostate cancer. Urology 2007;70(6):1104-8. (Pubitemid 350297379)
14. Kelley D, Mitrakou A, Marsh H, et al. Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load. Journal of Clinical Investigation 1988;81(May (5)):1563-71.
15. Bays H, Mandarino L, DeFronzo RA. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. Journal of Clinical Endocrinology and Metabolism 2004;89(February (2)):463-78. (Pubitemid 38269844)
16. Atlantis E, Martin SA, Haren MT, et al. Demographic, physical and lifestyle factors associated with androgen status: the Florey Adelaide Male Ageing Study (FAMAS). Clinical Endocrinology 2009;71(2):261-72.
17. Atlantis E, Martin SA, Haren MT, Taylor AW,Wittert GA, For the Florey Adelaide Male Aging Study. Lifestyle factors associated with age-related differences in body composition: the Florey Adelaide Male Aging Study. American Journal of Clinical Nutrition 2008;88(July (1)):95-104. (Pubitemid 351988688)
18. Tirosh A, Shai I, Bitzur R, et al. Changes in triglyceride levels over time and risk of type 2 diabetes in young men. Diabetes Care 2008;31(October (10)):2032-7.
19. Atlantis E, Martin SA, Haren MT, Taylor AW, Wittert GA. Inverse associations between muscle mass, strength, and the metabolic syndrome. Metabolism 2009;58(7):1013-22.
20. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement: executive summary. Circulation 2005;112(October (17)):e285-90.
21. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Construction of a surrogate variable for impotence in the Massachusetts male aging study. Journal of Clinical Epidemiology 1994;47(5):457-67. (Pubitemid 24171210)
22. Barry MJ, Fowler Jr FJ, O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. the Measurement Committee of the American Urological Association. Journal of Urology 1992;148(November (5)):1549-57 [discussion 64].
23. Maislin G, Pack AI, Kribbs NB, et al. A survey screen for prediction of apnea. Sleep 1995;18(April (3)):158-66.
24. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 1961;June (4):561-71.
25. Bennett CM, Guo M, Dharmage SC. HbA1c as a screening tool for detection of Type 2 diabetes: a systematic review. Diabetic Medicine 2007;24(4):333-43. (Pubitemid 46452406)
26. McNutt L-A, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. American Journal of Epidemiology 2003;157(May (10)):940-3. (Pubitemid 36555054)
27. Sundar N, Stuart RL, Eric R. A simple method of determining confidence intervals for population attributable risk from complex surveys. Statistics in Medicine 2007;26(17):3229-39.
28. Lakshman KM, Bhasin S, Araujo AB. Sex hormone-binding globulin as an independent predictor of incident type 2 diabetes mellitus in men. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2010;65(May (5)):503-9.
29. Yeap BB, Chubb SA, Hyde Z, et al. Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study. European Journal of Endocrinology 2009;161(October (4)): 591-8.
30. Chubb SA, Hyde Z, Almeida OP, et al. Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study. European Journal of Endocrinology 2008;158(June (6)):785-92. (Pubitemid 351837366)
31. Levy ME, Perera S, van Londen GJ, Nelson JB, Clay CA, Greenspan SL. Physical function changes in prostate cancer patients on androgen deprivation therapy: a 2-year prospective study. Urology 2008;71(4):735-9.
32. Allan CA, Strauss BJG, Burger HG, Forbes EA, McLachlan RI. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men. Journal of Clinical Endocrinology and Metabolism 2008;93(January (1)):139-46.
33. Travison TG, Araujo AB, Kupelian V, O'Donnell AB, McKinlay JB. The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. Journal of Clinical Endocrinology and Metabolism 2007;92(February (2)):549-55.
34. Khoo J, Piantadosi C, Worthley S, Wittert GA. Effects of a low-energy diet on sexual function and lower urinary tract symptoms in obese men. International Journal of Obesity 2010;34(9):1396-403.
35. Reis LO, Favaro WJ, Barreiro GC, et al. Erectile dysfunction and hormonal imbalance in morbidly obese male is reversed after gastric bypass surgery: a prospective randomized controlled trial. International Journal of Andrology 2010;33(5):736-44.
36. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine 2001;344(May (18)):1343-50. (Pubitemid 32378388)
37. Alberti KG, Zimmet P, Shaw J. International Diabetes Federation: a consensus on Type 2 diabetes prevention. Diabetic Medicine 2007;24(May (5)):451-63.
38. YialamasMA,DwyerAA, Hanley E, Lee H, Pitteloud N, Hayes FJ. Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism 2007;92(November (11)):4254-9. (Pubitemid 350074740)
39. Lapauw B, T'Sjoen G, Mahmoud A, Kaufman JM, Ruige JB. Short-term aromatase inhibition: effects on glucose metabolism and serum leptin levels in young and elderly men. European Journal of Endocrinology 2009;160(March (3)):397-402.
40. Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS, Jones TH. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. Journal of Clinical Endocrinology and Metabolism 2004;89(July (7)):3313-8. (Pubitemid 38951897)
41. Norata GD, Tibolla G, Seccomandi PM, Poletti A, Catapano AL. Dihydrotestosterone decreases tumor necrosis factor-{alpha} and lipopolysaccharideinduced inflammatory response in human endothelial cells. Journal of Clinical Endocrinology and Metabolism 2006;91(February (2)):546-54. (Pubitemid 43236925)
42. Pitteloud N, Mootha VK, Dwyer AA, et al. Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care 2005;28(July (7)):1636-42. (Pubitemid 41340902)
43. Petersen KF, Befroy D, Dufour S, et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003;300(May (5622)):1140-2. (Pubitemid 36583097)
44. Haren MT, Siddiqui AM, Armbrecht HJ, Kevorkian RT, Kim MJ, Haas MJ, Mazza A, Kumar VB, Green M, Banks WA, Morley JE. Testosterone modulates gene expression pathways regulating nutrient accumulation, glucose metabolism and protein turnover in mouse skeletal muscle. Int J Androl. 2010 Apr 6. doi: 10.1111/j.1365-2605.2010.01061.x [Epub ahead of print].
45. Park SW, Goodpaster BH, Lee JS, et al. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care 2009.
46. Baliunas DO, Taylor BJ, Irving H, et al. Alcohol as a risk factor for type 2 diabetes. Diabetes Care 2009;32(11):2123-32.
47. Wang L, Lee I-M,Manson JE, Buring JE, Sesso HD. Alcohol consumption, weight gain, and risk of becoming overweight in middle-aged and older women. Archives of Internal Medicine 2010;170(5):453-61.
48. Hayashino Y, Hennekens CH, Kurth T. Aspirin use and risk of type 2 diabetes in apparently healthy men. The American Journal of Medicine 2009;122(4):374-9.
49. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2007;298(22):2654-64. (Pubitemid 350254957)
50. Karin SC, Steven AK, Christopher RC, et al. Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS. BJU International 2009;103(s3):24-32.
51. Barr ELM, Magliano DJ, Zimmet PZ, et al. AusDiab 2005 the Australian Diabetes, Obesity and Lifestyle Study. Melbourne, Australia: International Diabetes Institute; 2006.
52. Bain J. Testosterone and the aging male: to treat or not to treat? Maturitas 2010;66(1):16-22.